SCHEMBL6972695

SCHEMBL6972695

CN(C)C(=O)c1ccc(C=CC(=O)NCC(=O)N(C)c2ccc(Cl)c(COS(C)(=O)=O)c2Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972693 1.00 BDKRB2 (0.64) BDKRB2
SCHEMBL6976001 0.86 BDKRB2 (0.64) BDKRB2
SCHEMBL6976005 0.86 BDKRB2 (0.64) BDKRB2
SCHEMBL6975063 0.81 BDKRB2 (0.63) BDKRB2
SCHEMBL6972291 0.80 BDKRB2 (0.52) BDKRB2
SCHEMBL7006007 0.79 BDKRB2 (0.60) BDKRB2
SCHEMBL7006011 0.79 BDKRB2 (0.60) BDKRB2
SCHEMBL7750170 0.79 BDKRB2 (1.00) BDKRB2
SCHEMBL7750177 0.79 BDKRB2 (1.00) BDKRB2
Hydrochloric Acid SCHEMBL7746629 0.78 BDKRB2 (1.00) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900203-B1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-03-19 EP disclosed
US-6083959-A BRADYKININ ANTAGONISTS; FOR THE PREVENTION AND/OR THE TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0900203-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 EP disclosed
WO-1997041104-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-06 WO disclosed